Dianthus Therapeutics DNTH
NASDAQ DNTH
$77.18 -0.92 (-1.17%)
As of: Oct 22, 2026 · 11:25 AM EDT

Dianthus Therapeutics (DNTH) Long-Term Debt Issuances (2023)

Updated

Dianthus Therapeutics' Long-Term Debt Issuances came in at $377,000 for FY2023.

Analysis

Dianthus Therapeutics (DNTH) Long-Term Debt Issuances (2023) Analysis & Trends

  • The FY2023 figure represents the highest annual Long-Term Debt Issuances since FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,175.94 Bn 1,144.53 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 638.47 Bn 556.99 Bn 17.26 Bn -
3 AbbVie 504.39 Bn 477.51 Bn 12.70 Bn -
4 Merck 377.60 Bn 331.98 Bn 12.21 Bn -
5 Novartis Ag 304.31 Bn 268.30 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.64 Bn 241.32 Bn 12.86 Bn -
7 Amgen 242.06 Bn 197.45 Bn 7.24 Bn -
8 Gilead Sciences 193.83 Bn 168.03 Bn 6.22 Bn -
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn -
10 Dianthus Therapeutics 2.92 Bn 2.87 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 377,000.00
API Access

Dianthus Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=DNTH&period=max&api_key=YOUR_API_KEY